1-5 of 5
Peter J Lenting
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Allele-selective Disruption of Pathogenic VWF Variants in Type 2 Von Willebrand Disease using CRISPR/Cas9

Open Access
Isabel Bär, Stijn A. Groten, Alastair Barraclough, Petra E. Bürgisser, Calvin van Kwawegen, Peter J Lenting, Iris van Moort, Jeroen C.J. Eikenboom, Frank W.G. Leebeek, Jan Voorberg, Maartje van den Biggelaar, Ruben Bierings
Journal: Blood Advances
Blood Adv bloodadvances.2025018760.
https://doi.org/10.1182/bloodadvances.2025018760
Published: 2025
Includes: Supplemental data
Journal Articles

Modeling Response to High-Purity Von Willebrand Factor: Toward Tailored Dosing During Surgery in von Willebrand Disease

Open Access
Melanie Y Daniel, Antoine Rauch, Camille Paris, Emmanuelle Jeanpierre, Jenny Goudemand, Catherine Marichez, Benedicte Pradines, Christophe Zawadzki, Annabelle Dupont, Cécile V. Denis, Peter J Lenting, Sophie Susen, Xavier Delavenne
Journal: Blood Advances
Blood Adv bloodadvances.2025017898.
https://doi.org/10.1182/bloodadvances.2025017898
Published: 2025
Includes: Supplemental data
Journal Articles

Gene therapy for hemophilia

Free
Peter J. Lenting, Sylvia Fong
Journal: Blood Advances
Blood Adv (2024) 8 (23): 6081.
https://doi.org/10.1182/bloodadvances.2024013864
Published: 2024
Journal Articles

Laboratory monitoring of hemophilia A treatments: new challenges

Free
Clinical Trials & Observations
Peter J. Lenting
Journal: Blood Advances
Blood Adv (2020) 4 (9): 2111–2118.
https://doi.org/10.1182/bloodadvances.2019000849
Published: 2020
Journal Articles

Protein kinase C signaling dysfunction in von Willebrand disease (p.V1316M) type 2B platelets

Free
Caterina Casari, David S. Paul, Sophie Susen, Cécile Lavenu-Bombled, Annie Harroche, Raymond Piatt, Kathryn O. Poe, Robert H. Lee, Marijke Bryckaert, Olivier D. Christophe, Peter J. Lenting, Cécile V. Denis, Wolfgang Bergmeier
Journal: Blood Advances
Blood Adv (2018) 2 (12): 1417–1428.
https://doi.org/10.1182/bloodadvances.2017014290
Published: 2018
Includes: Supplemental data